325
Views
10
CrossRef citations to date
0
Altmetric
Original Research

A 2-year post-authorization safety study of high-strength pancreatic enzyme replacement therapy (pancreatin 40,000) in cystic fibrosis

, , , &
Pages 197-203 | Published online: 23 Feb 2011

Bibliography

  • Littlewood JM, Wolfe SP, Conway SP. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis. Pediatr Pulmonol 2006;41:35-49
  • Committee on Safety of Medicines/Medicines Control Agency. Fibrosing colonopathy associated with pancreatic enzymes. Curr Probl Pharmacovigilance 1995;21:11
  • Pancreatic enzyme supplements and fibrosing colonopathy. WHO Drug Information 1996;10(1):43-4
  • Prescott P, Bakowski MT. Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer. Pharmacoepidemiol Drug Saf 1999;8:377-84
  • FitzSimmons SC, Burkhart GA, Borowitz D, High-dose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997;336:1283-9
  • Sinaasappel M, Stern M, Littlewood J, Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros 2002;1:51-75
  • Borowitz DS, Grand RJ, Durie PR. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus Committee. J Pediatr 1995;127:681-4
  • Stallings VA, Stark LJ, Robinson KA, Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008;108:832-9
  • Mehta A. Further comments on fibrosing colonopathy study [letter]. Lancet 2001;358:1546-7
  • Lohr M, Hummel FM, Pirilis T, Properties of different pancreatin preparations used in pancreatic exocrine insufficiency. Eur J Gastroenterol Hepatol 2009;21:1024-31
  • Houwen RH, van der Doef HP, Sermet I, Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS. J Pediatr Gastroenterol Nutr 2010;50:38-42
  • Littlewood JM. Abdominal pain in cystic fibrosis. J R Soc Med 1995;88(Suppl 25):9-17
  • Smyth RL, Ashby D, O'Hea U, Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995;346:1247-51
  • O'Hara D, Talbot IC. Further comments on fibrosing colonopathy study [letter]. Lancet 2001;358:1546
  • Dodge JA. Further comments on fibrosing colonopathy study [letter]. Lancet 2001;358:1546
  • Franzen D, Went P, Buhlmann U. Fibrosing colonopathy in absence of pancreatic enzyme supplementation in one adult patient with cystic fibrosis. Indian J Gastroenterol 2008;27:133-4
  • Waters BL. Cystic fibrosis with fibrosing colonopathy in the absence of pancreatic enzymes. Pediatr Dev Pathol 1998;1:74-8
  • Serban DE, Florescu P, Miu N. Fibrosing colonopathy revealing cystic fibrosis in a neonate before any pancreatic enzyme supplementation. J Pediatr Gastroenterol Nutr 2002;35:356-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.